seer-brandmark-rgb - full.jpg
Seer Reports First Quarter 2021 Financial Results
May 10, 2021 16:05 ET | Seer, Inc.
Second Phase of Commercialization Advances with the Addition of Multiple Limited Release Customers REDWOOD CITY, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences...
seer-brandmark-rgb - full.jpg
Seer to Present at the BofA Securities 2021 Healthcare Conference
May 04, 2021 16:05 ET | Seer, Inc.
REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be...
seer-brandmark-rgb - full.jpg
Seer to Report First Quarter Financial Results on May 10, 2021
April 12, 2021 16:05 ET | Seer, Inc.
REDWOOD CITY, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report...
seer-brandmark-rgb - full.jpg
Seer and SCIEX Sign Commercial Agreement to Offer End-to-End Unbiased Proteomics Solutions
March 29, 2021 16:05 ET | Seer, Inc.
REDWOOD CITY, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Seer (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, announced today that they have signed...
seer-brandmark-rgb - full.jpg
Seer Reports Fourth Quarter and Full Year 2020 Financial Results and Fuels Commercial Progress in 2021 with New Collaborators and Partnerships
March 29, 2021 16:05 ET | Seer, Inc.
REDWOOD CITY, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
seer-brandmark-rgb - full.jpg
Seer to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021
March 01, 2021 08:05 ET | Seer, Inc.
REDWOOD CITY, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report...
seer-brandmark-rgb - full.jpg
Seer to Present at the Cowen 41st Annual Healthcare Conference
February 24, 2021 16:05 ET | Seer, Inc.
REDWOOD CITY, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be...
Seer Appoints Deep Nishar and Mostafa Ronaghi, Ph.D. to its Board of Directors
February 17, 2021 08:00 ET | Seer, Inc.
REDWOOD CITY, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed...
seer-brandmark-rgb - full.jpg
Seer Announces Closing of Public Offering of Common Stock
February 01, 2021 16:05 ET | Seer, Inc.
REDWOOD CITY, Calif. , Feb. 01, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the closing of an underwritten...
seer-brandmark-rgb - full.jpg
Seer Announces Pricing of Upsized Public Offering of Common Stock
January 27, 2021 22:51 ET | Seer, Inc.
REDWOOD CITY, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the pricing of an underwritten...